J.R.S. Oryx Pharmaceuticals Pvt Ltd

J.R.S. Oryx Pharmaceuticals Pvt Ltd - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
CIN U85110HR1993PTC031972 Incorporated 16 April 1993 ROC Delhi HQ Karnal, Haryana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹3.75 Cr
▼ 13% YoY
Net profit · FY 2025
₹94,000
Net margin 0.3%
EBITDA · FY 2025
₹31.43 Lakh
EBITDA margin 8.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹26.45 Lakh
Issued & subscribed
Open charges
₹3.04 Cr
Satisfied ₹1.77 Cr
Company age
33 yrs
Est. 1993
Directors on board
2
As per MCA filings

About J.R.S. Oryx Pharmaceuticals Pvt Ltd

Data last updated:

J.R.S. Oryx Pharmaceuticals Pvt Ltd is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110HR1993PTC031972. Its GSTIN is 06AAACJ4310K1ZV (Haryana).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹26.45 Lakh. It is led by directors Surinder Pal and Parveen Goyal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.75 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹94,000 (net margin 0.3%) and EBITDA of ₹31.43 Lakh (EBITDA margin 8.4%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.

As per MCA filings, the company has open charges of ₹3.04 Cr and satisfied charges of ₹1.77 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jrsoryxpharma.com.

Company details

CIN U85110HR1993PTC031972
Registration Number 031972
Incorporation Date 16 April 1993
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

J.R.S. Oryx Pharmaceuticals Pvt Ltd's registered office is in Karnal, Haryana. Its website is jrsoryxpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Comprehensive company report
J.R.S. Oryx Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of J.R.S. Oryx Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Financials of J.R.S. Oryx Pharmaceuticals Pvt Ltd

FY 2025 filings available

J.R.S. Oryx Pharmaceuticals Pvt Ltd reported revenue of ₹3.75 Cr (down 13% YoY) for FY 2025.

Revenue · FY 2025
₹3.75 Cr ▼ 13%
Net profit · FY 2025
₹94,000 margin 0.3%
EBITDA · FY 2025
₹31.43 Lakh margin 8.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 6%
5 years · compounded
▲ 6%

Revenue has declined at a compounded annual rate (CAGR) of 9% over three years, including a 13% fall in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31.43 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹94,000
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.4%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of J.R.S. Oryx Pharmaceuticals Pvt Ltd

J.R.S. Oryx Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Surinder PalDirector26 Apr 199333 Years 6 MonthsCurrent
Parveen GoyalDirector05 Feb 20251 Years 9 MonthsCurrent

Auditor

J.R.S. Oryx Pharmaceuticals Pvt Ltd is audited by P CHOPRA & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
P CHOPRA & COFY 2021004957N

Shareholding

The shareholding of J.R.S. Oryx Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Charges & borrowings

Open charges
₹3.04 Cr
Satisfied charges
₹1.77 Cr
Breakdown by lending institutions
Others₹3.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Apr 2018100215901Others₹3.04 CrOpen
17 Sep 2020100368825Others₹30 LakhSatisfied
09 Feb 201510573551L & T Finance Limited₹2.5 LakhSatisfied
18 Jun 201310438127Capital First Limited₹91.5 LakhSatisfied
26 May 200610012321Bank of Punjab Limited₹25 LakhSatisfied

To see the full charge records of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for J.R.S. Oryx Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

J.R.S. Oryx Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAACJ4310K1ZVHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of J.R.S. Oryx Pharmaceuticals Pvt Ltd, buy the company report.

Recent activity

J.R.S. Oryx Pharmaceuticals Pvt Ltd has 5 board changes on record since 1993: 2 appointments and 3 cessations. The latest: Rattan Lal Sharma ceased to be Director on 10 Feb 2025.

AGM
J.R.S. Oryx Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 303.50 Lakh registered on 20 Apr 2018 with Charge ID 100215901 was modified on 29 Apr 2025.
Filing
J.R.S. Oryx Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Rattan Lal Sharma ceased to be Director.
Appointed
Parveen Goyal was appointed as Director.
Charges
A charge registered on 17 Sep 2020 via Charge ID 100368825 with Others was fully satisfied on 16 Mar 2022.
Charges
A charge registered on 09 Feb 2015 via Charge ID 10573551 with L & T Finance Limited was fully satisfied on 02 Feb 2022.
Charges
A charge registered on 18 Jun 2013 via Charge ID 10438127 with Capital First Limited was fully satisfied on 02 Feb 2022.
Charges
A charge with Others amounted to Rs. 30.00 Lakh with Charge ID 100368825 was registered on 17 Sep 2020.
Charges
A charge with Others amounted to Rs. 303.50 Lakh with Charge ID 100215901 was registered on 20 Apr 2018.
Charges
A charge with L & T Finance Limited amounted to Rs. 2.50 Lakh with Charge ID 10573551 was registered on 09 Feb 2015.
Charges
A charge with Capital First Limited of Rs. 91.50 Lakh registered on 18 Jun 2013 with Charge ID 10438127 was modified on 17 Dec 2014.

12 earlier events are in the company report.

Frequently asked questions

J.R.S. Oryx Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 1993 (33+ years old) and is registered under CIN U85110HR1993PTC031972.

J.R.S. Oryx Pharmaceuticals has 2 current directors:

The latest financial statements of J.R.S. Oryx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of J.R.S. Oryx Pharmaceuticals is 06AAACJ4310K1ZV, registered in Haryana.

The CIN (Corporate Identification Number) of J.R.S. Oryx Pharmaceuticals is U85110HR1993PTC031972. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

J.R.S. Oryx Pharmaceuticals has 7 court cases on record: 3 filed by the company and 4 filed against it. 1 is pending. Most are in the high courts.

J.R.S. Oryx Pharmaceuticals was incorporated on 16 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Delhi.

Rattan Lal Sharma ceased to be Director on 10 Feb 2025. Parveen Goyal was appointed as Director on 05 Feb 2025. Nathi Ram Verma ceased to be Director on 01 Apr 2013. J.R.S. Oryx Pharmaceuticals has 5 board changes on record in total.

J.R.S. Oryx Pharmaceuticals can be reached through the website jrsoryxpharma.com. Its registered office is in Karnal, Haryana, India.

The registered office of J.R.S. Oryx Pharmaceuticals is at 217& 218 Sector – 3 Hsiidc Industrial Area, Karnal, Haryana, India – 132001.